Investigating the effectiveness of probiotics in the newborns
Phase 3
Recruiting
- Conditions
- Jaundice in infants and acceleration of treatment.Neonatal jaundice from other and unspecified causes
- Registration Number
- IRCT20231020059774N1
- Lead Sponsor
- Shahid Beheshti University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
A newborn with a birth weight of more than 2 kg
Childbirth age greater than 37 weeks
Non-physiological jaundice and bilirubin more than 15
A newborn with bilirubin less than 25
A newborn doesnot need blood transfusion
A newborn without abnormalities and comorbidities
Parental consent
Exclusion Criteria
A newborn less than 2 days old
Childbirth age less than 35 weeks
Pathological jaundice
A newborn with bilirubin above 20
A newborn with malformations and other co-morbidities
A newborn needs a blood transfusion
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Rapid decrease in bilirubin?. Timepoint: The beginning of hospitalization and the course of treatment and the time of discharge. Method of measurement: Bilirubin level in blood test.
- Secondary Outcome Measures
Name Time Method